Translational Development... (TDACU)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Translational Development Acquisition Corp. Statistics
Share Statistics
Translational Development Acquisition Corp. has - shares outstanding. The number of shares has increased by null% in one year.
Shares Outstanding | - |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Institutions (%) | n/a |
Shares Floating | - |
Failed to Deliver (FTD) Shares | 500 |
FTD / Avg. Volume | 0.22% |
Short Selling Information
The latest short interest is 0, so 0% of the outstanding shares have been sold short.
Short Interest | 0 |
Short % of Shares Out | 0% |
Short % of Float | 0% |
Short Ratio (days to cover) | 0 |
Valuation Ratios
The PE ratio is -107.8 and the forward PE ratio is null.
PE Ratio | -107.8 |
Forward PE | null |
PS Ratio | 0 |
Forward PS | null |
PB Ratio | 1.61 |
P/FCF Ratio | -47.17 |
PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Translational Development Acquisition Corp..
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.19, with a Debt / Equity ratio of 0.09.
Current Ratio | 0.19 |
Quick Ratio | 0.19 |
Debt / Equity | 0.09 |
Total Debt / Capitalization | 8.56 |
Cash Flow / Debt | -0.36 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.01% and return on capital (ROIC) is -1.84%.
Return on Equity (ROE) | -0.01% |
Return on Assets (ROA) | -0.01% |
Return on Capital (ROIC) | -1.84% |
Revenue Per Employee | - |
Profits Per Employee | - |
Employee Count | - |
Asset Turnover | 0 |
Inventory Turnover | 0 |
Taxes
Income Tax | -217.09K |
Effective Tax Rate | 0.21 |
Stock Price Statistics
The stock price has increased by -45.55% in the last 52 weeks. The beta is 0.09, so Translational Development Acquisition Corp.'s price volatility has been higher than the market average.
Beta | 0.09 |
52-Week Price Change | -45.55% |
50-Day Moving Average | null |
200-Day Moving Average | null |
Relative Strength Index (RSI) | 0.97 |
Average Volume (20 Days) | 228.46K |
Income Statement
Revenue | n/a |
Gross Profit | 0 |
Operating Income | -1.39M |
Net Income | -809.05K |
EBITDA | -1.03M |
EBIT | n/a |
Earnings Per Share (EPS) | -0.11 |
Balance Sheet
The company has 972.79K in cash and 5.08M in debt, giving a net cash position of -4.10M.
Cash & Cash Equivalents | 972.79K |
Total Debt | 5.08M |
Net Cash | -4.10M |
Retained Earnings | 3.13M |
Total Assets | 58.40M |
Working Capital | -10.22M |
Cash Flow
In the last 12 months, operating cash flow was -1.85M and capital expenditures 0, giving a free cash flow of -1.85M.
Operating Cash Flow | -1.85M |
Capital Expenditures | 0 |
Free Cash Flow | -1.85M |
FCF Per Share | -0.25 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TDACU does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -1.1% |
FCF Yield | -0.26% |
Analyst Forecast
Currently there are no analyst rating for TDACU.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | -325759.9 |
Piotroski F-Score | 4 |